Rana R. McKay, MD - Practice Series on Translating Data Into Practice in mCRPC: The Evolving Role of Radiopharmaceuticals PeerVoice Oncology & Haematology Audio

Visit https://www.peervoice.com/GJD860 to view the entire programme with slides. After completing “Rana R. McKay, MD - Practice Series on Translating Data Into Practice in mCRPC: The Evolving Role of Radiopharmaceuticals”, participants will be able to: Propose the most appropriate sequence of life-prolonging agents, including radiopharmaceuticals, for patients with metastatic castration-resistant prostate cancer (mCRPC); Evaluate clinical trial data guiding the use of radiopharmaceuticals within the overall treatment paradigm for mCRPC; and Design holistic therapeutic regimens to maximise patient quality of life through optimisation of bone health and clear communication of treatment expectations.